NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan · Delayed Price · Currency is TWD 18.50
+0.80 (4.52%)
Jun 18, 2026, 2:59 PM CST
TPEX:4732 Market Cap
TPEX:4732 has a market cap or net worth of 869.55 million as of June 18, 2026. Its market cap has decreased by -10.61% in one year.
Market Cap
869.55M
Enterprise Value
427.08M
Revenue
176.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.50
Market Cap Chart
Since December 25, 2007, TPEX:4732's market cap has increased from 285.93M to 869.55M, an increase of 204.12%. That is a compound annual growth rate of 6.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 869.55M | -10.84% |
| Dec 31, 2025 | 975.30M | -20.71% |
| Dec 31, 2024 | 1.23B | -8.42% |
| Dec 29, 2023 | 1.34B | -22.70% |
| Dec 30, 2022 | 1.74B | -31.42% |
| Dec 30, 2021 | 2.53B | 109.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.06B |
| Level Biotechnology | 1.02B |
| GeneReach Biotechnology | 991.34M |
| TCI GENE | 978.96M |
| U-Neuron Biomedical | 973.67M |
| Taiwan Advance Bio-Pharmaceutical | 913.50M |
| Meribank Biotech | 910.81M |
| MegaPro Biomedical | 825.19M |